keyword
https://read.qxmd.com/read/38652434/short-and-long-term-post-nephrectomy-outcomes-for-retroperitoneal-liposarcoma-from-a-high-volume-sarcoma-center-a-propensity-score-matching-analysis
#1
JOURNAL ARTICLE
Guoqiang Xue, Zhen Wang, Bonan Liu, Chengpeng Li, Ang Lv, Xiuyun Tian, Jianhui Wu, Hui Qiu, Chunyi Hao
BACKGROUND: Multivisceral en bloc resection with the ipsilateral kidney is commonly performed in patients with retroperitoneal liposarcoma (RLPS). We evaluated the effect of nephrectomy on short- and long-term outcomes in patients with RLPS. METHODS: Data from a prospectively maintained database of the Peking University Cancer Hospital Sarcoma Center between April 2011 and August 2022 were analyzed. We classified the RLPS patients who underwent surgery into nephrectomy group (NP) and non-nephrectomy group (non-NP)...
April 23, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38634962/en-bloc-inferior-vena-cava-ivc-resection-without-reconstruction-with-right-hepatectomy-and-right-nephrectomy-for-a-large-ivc-leiomyosarcoma
#2
JOURNAL ARTICLE
Gurudutt P Varty, Shraddha Patkar, Kunal Nandy, Mahesh Goel
BACKGROUND: Radical resection remains the only potential cure in the management of inferior vena cava (IVC) leiomyosarcomas with multivisceral resections often needed (Borghi et al. in J Cardiovasc Surg (Torino) 63:649-663, 2022). This video describes the technical nuances of surgical resection of a large retrohepatic IVC leiomyosarcoma. PATIENT AND METHODS: Computed tomography of a 60-year-old woman revealed a 12 × 12 × 9.5 cm mass in the right suprarenal region infiltrating the IVC with intraluminal extension up to the hepatic venous confluence...
April 18, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38622699/a-case-study-of-abdominal-wall-and-limb-necrotizing-fasciitis-an-extremely-rare-post-operative-complication
#3
JOURNAL ARTICLE
Saida Sakhri, Ons Krimi, Nayssem Khessairi, Fethia Abidi, Maher Slimane, Hanen Bouaziz, Tarek Ben Dhiab
INTRODUCTION: Infectious affections are the most frequent post-operative complications, the rate have been reducing due to the administration of perioperative antibiotics and they are rarely serious. They are usually associated to pelvic collections, fistulas, urinary tract stenosis and, exceptionally, necrotizing fasciitis (FN) and pelvic organ necrosis. There is no well-codified treatment. CASE PRESENTATION: A 42-year-old female patient, was referred to our department for a stage IIIC2 adenocarcinoma of the uterine cervix...
April 15, 2024: BMC Women's Health
https://read.qxmd.com/read/38580539/tolerance-in-intestinal-transplantation
#4
REVIEW
Megan Sykes
Intestinal transplantation (ITx) is highly immunogenic, resulting in the need for high levels of immunosuppression, with frequent complications along with high rejection rates. Tolerance induction would provide a solution to these limitations. Detailed studies of alloreactive T cell clones as well as multiparameter flow cytometry in the graft and peripheral tissues have provided evidence for several tolerance mechanisms that occur spontaneously following ITx, which might provide targets for further interventions...
April 5, 2024: Human Immunology
https://read.qxmd.com/read/38577068/feasibility-and-safety-of-minimally-invasive-multivisceral-resection-for-t4b-rectal-cancer-a-9-year-review
#5
JOURNAL ARTICLE
Kai Siang Chan, Biquan Liu, Ming Ngan Aloysius Tan, Kwang Yeong How, Kar Yong Wong
BACKGROUND: Colorectal cancer is the third most common cancer and the second highest cause of cancer-related mortality worldwide. About 5%-10% of patients are diagnosed with locally advanced rectal cancer (LARC) on presentation. For LARC invading into other structures ( i.e. T4b), multivisceral resection (MVR) and/or pelvic exenteration (PE) remains the only potential curative surgical treatment. MVR and/or PE is a major and complex surgery with high post-operative morbidity. Minimally invasive surgery (MIS) has been shown to improve short-term post-operative outcomes in other gastrointestinal malignancies, but there is little evidence on its use in MVR, especially so for robotic MVR...
March 27, 2024: World Journal of Gastrointestinal Surgery
https://read.qxmd.com/read/38576073/perioperative-and-oncological-outcomes-following-robotic-en-bloc-multivisceral-resection-for-colorectal-cancer
#6
JOURNAL ARTICLE
Sandra R DiBrito, Naveen Manisundaram, Youngwan Kim, Oliver Peacock, Chung-Yuan Hu, Brian Bednarski, Y Nancy You, Abhineet Uppal, Matthew Tillman, Tsuyoshi Konishi, Harmeet Kaur, Sarah Palmquist, Emma Holliday, Arvind Dasari, George J Chang
AIM: As multidisciplinary treatment strategies for colorectal cancer have improved, aggressive surgical resection has become commonplace. Multivisceral and extended resections offer curative-intent resection with significant survival benefit. However, limited data exist regarding the feasibility and oncological efficacy of performing extended resection via a minimally invasive approach. The aim of this study was to determine the perioperative and long-term outcomes following robotic extended resection for colorectal cancer...
April 4, 2024: Colorectal Disease
https://read.qxmd.com/read/38553440/complete-remission-of-metastatic-melanoma-of-the-scalp-following-treatment-with-nivolumab-plus-relatlimab
#7
JOURNAL ARTICLE
Mary E McMinn, Kelly A Brister, W Shannon Orr, Natale T Sheehan, Wade O Christopher
Melanoma is an aggressive malignancy accounting for approximately 1% of all skin cancers. The standard of care for distant melanoma of the skin is immunotherapy with PD-1 inhibitors (nivolumab) or CTLA-4 inhibitors. In March 2022, the FDA approved the combination of nivolumab with relatlimab, a lymphocyte-activation gene 3 antibody. There are few reports on the efficacy of treating widespread multivisceral metastatic melanoma with nivolumab plus relatlimab with a complete clinical response. We describe the diagnosis and management of a patient with metastatic nodular melanoma treated with palliative resection of the primary tumor followed by immunotherapy with nivolumab and relatlimab...
March 29, 2024: American Surgeon
https://read.qxmd.com/read/38552415/factors-associated-with-one-year-mortality-after-curative-surgery-for-primary-clinical-t4-and-locally-recurrent-rectal-cancer-in-elderly-patients
#8
JOURNAL ARTICLE
Nikki C M van Ham, Sofie Glazemakers, Mirjam van der Ende-van Loon, Grard A P Nieuwenhuijzen, Harm J T Rutten, Jip L Tolenaar, Anne Jacobs, Jacobus W A Burger, Stijn H J Ketelaers, Johanne G Bloemen
INTRODUCTION: Despite advancements in colorectal cancer care, one-year post-operative mortality rates remain high for elderly patients who have undergone curative surgery for primary clinical T4 rectal cancer (cT4RC) or locally recurrent rectal cancer (LRRC). This study aimed to identify factors associated with one-year mortality and to evaluate the causes of death. MATERIALS & METHODS: This retrospective cohort study included patients aged ≥70 years who underwent surgery with curative intent for cT4RC or LRRC between January 2013 and December 2020...
March 19, 2024: European Journal of Surgical Oncology
https://read.qxmd.com/read/38531046/experience-with-laparoscopic-and-robotic-colon-surgery-together-with-other-major-minimally-invasive-procedures-for-unrelated-pathologies
#9
JOURNAL ARTICLE
Hugo J R Bonatti
Background: Indications for combined colon surgery together with other procedures include oncologic multivisceral resections and abdominal trauma. It is unclear if combining minimally invasive (MI) colon surgery with unrelated other procedures increases the risk for complications. Patients and Methods: The surgical database from two institutions during a 10-year period was queried for combined colon surgeries together with other interventions. All open cases, combined cases performed for one pathology and MI colectomies together with a minor procedure, were excluded...
March 27, 2024: Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A
https://read.qxmd.com/read/38523226/aso-visual-abstract-comparing-multivisceral-resection-with-tumor-only-resection-of-liposarcoma-using-the-win-ratio
#10
JOURNAL ARTICLE
Leva Gorji, Melica Nikahd, Amblessed Onuma, Diamantis Tsilimigras, J Madison Hyer, Samantha Ruff, Farhan Z Ilyas, Carlo Contreras, Valerie P Grignol, Alex Kim, Raphael Pollock, Timothy M Pawlik, Joal D Beane
No abstract text is available yet for this article.
March 24, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38519405/history-of-clinical-intestinal-transplantation
#11
REVIEW
Gabriel E Gondolesi
The intestines have been considered the "forbidden organ" for years, and intestinal failure became the last organ failure recognized as such in the medical field. The impossibility of providing adequate nutritional support, turned these patients into recipients of just palliative comfort. In the 1960's, parenteral nutrition appeared as the most reasonable replacement therapy, but the initial success obtained with clinical kidney, heart, liver, lung and pancreas transplantation served as background to explore intestinal transplantation...
March 21, 2024: Human Immunology
https://read.qxmd.com/read/38465712/risk-factors-associated-with-ptld-related-mortality-in-adult-multivisceral-transplant-recipients-a-single-centre-cohort-study
#12
JOURNAL ARTICLE
Mihnea-Ioan Ionescu, Samantha Ip, Jessica K Barrett, George Follows, Andrew J Butler, Lisa M Sharkey
Background: PTLD is a heterogeneous group of lymphoproliferative diseases which can add significant mortality following multivisceral transplantation (MVTx). Our study aimed to identify potential risk factors of mortality in adult MVTx recipients who developed PTLD. Methods: All adult recipients of intestinal-containing grafts transplanted in our institution between 2013 and 2022, and who developed PTLD, were included in the study. Results: PTLD-associated mortality was 28.6% (6/21). Increased relative risk of mortality was associated with Stage 3 ECOG performance score (p=0...
February 2024: Chirurgia
https://read.qxmd.com/read/38461165/exploring-the-complexities-of-megacystis-microcolon-intestinal-hypoperistalsis-syndrome-insights-from-genetic-studies
#13
REVIEW
Prasad K V Devavarapu, Kalyan Ram Uppaluri, Vrushabh Anil Nikhade, Kalyani Palasamudram, Kavutharapu Sri Manjari
Megacystis microcolon intestinal hypoperistalsis syndrome (MMIHS) is an uncommon genetic disorder inherited in an autosomal recessive pattern that affects the muscles that line the bladder and intestines. The most common genes associated with MMIHS mutations are ACTG2, LMOD1, MYH11, MYL9, MYLK, and PDCL3. However, the complete genetic landscape of MMIHS still needs to be fully understood. The diagnosis of MMIHS can be challenging. However, advances in prenatal and diagnostic techniques, such as ultrasound and fetal urine analysis, have improved the ability to detect the syndrome early...
March 9, 2024: Clinical Journal of Gastroenterology
https://read.qxmd.com/read/38455807/endovascular-treatment-of-a-multi-visceral-aortic-conduit-blowout-with-parallel-stent-grafts-and-coils
#14
JOURNAL ARTICLE
Dimitrios Moris, Mitchell W Cox, Zachary Williams
Multi-visceral transplantation (MVT) is a complex surgical procedure involving the transplantation of multiple abdominal organs as a single unit, typically used as bailout treatment of patients with devastating abdominal pathologies. Due to the complexity of the procedure, major and even life-threatening complications can happen. Vascular complications, including anastomotic breakdowns or pseudoaneurysms due to infections, can be universally lethal. Open surgical repair is often not an option due to the hostile operative field...
February 2024: Curēus
https://read.qxmd.com/read/38445531/single-center-utilization-and-post-transplant-outcomes-of-thoracoabdominal-normothermic-regional-perfusion-deceased-cardiac-donor-organs
#15
JOURNAL ARTICLE
Jennifer D Motter, Ian S Jaffe, Nader Moazami, Deane E Smith, Zachary N Kon, Greta L Piper, Philip M Sommer, Alex Reyentovich, Stephanie H Chang, Imad Aljabban, Robert A Montgomery, Dorry L Segev, Allan B Massie, Bonnie E Lonze
INTRODUCTION: Thoracoabdominal normothermic regional perfusion (TA-NRP) following cardiac death is an emerging multivisceral organ procurement technique. Recent national studies on outcomes of presumptive TA-NRP-procured organs are limited by potential misclassification since TA-NRP is not differentiated from donation after cardiac death (DCD) in registry data. METHODS: We studied 22 donors whose designees consented to TA-NRP and organ procurement performed at our institution between January 20, 2020 and July 3, 2022...
March 2024: Clinical Transplantation
https://read.qxmd.com/read/38434926/a-multicenter-analysis-of-short-term-and-long-term-outcomes-following-laparoscopic-multivisceral-resection-for-advanced-colorectal-cancer
#16
JOURNAL ARTICLE
Sho Nambara, Ryota Nakanishi, Kentaro Nonaka, Yoshiaki Fujimoto, Qingjiang Hu, Tomonori Nakanoko, Masahiko Sugiyama, Mitsuhiko Ota, Yasue Kimura, Eiji Oki, Yasushi Toh, Tomoharu Yoshizumi
BACKGROUND/AIM: Recent research has demonstrated that laparoscopic multivisceral resection (MVR) for advanced colorectal cancer is safe, practicable, and yields satisfactory oncological results, which is in line with the growing usage of laparoscopic surgery. The effectiveness of laparoscopic MVR is still debatable, though. The goal of this study was to compare the short- and long-term results of patients with advanced colorectal cancer treated with open MVR with laparoscopic procedures...
2024: Cancer Diagn Progn
https://read.qxmd.com/read/38427034/-indications-and-results-of-intestinal-transplantation-for-short-bowel-syndrome-after-mesenteric-ischemia
#17
REVIEW
Andreas Pascher
BACKGROUND: Intestinal transplantation (ITx) is the only causal treatment for complicated chronic intestinal failure after mesenteric ischemia and impending failure of parenteral supplementation. Isolated or combined ITx with the inclusion of the intestine is associated with demanding immunological, perioperative and infection associated challenges. AIM: The characterization of chronic intestinal failure, the indications, transplant survival, transplantation techniques and success rates...
March 1, 2024: Chirurgie (Heidelb)
https://read.qxmd.com/read/38426495/the-multivisceral-landscape-of-colorectal-cancer-metastasis-implications-for-targeted-therapies
#18
JOURNAL ARTICLE
Dominik Wolf, Stefan Salcher, Andreas Pircher
Colorectal cancer (CRC) is among the most common cancer types and the second deadliest malignancy for both sexes. Metastatic disease poses substantial therapeutic challenges, and peritoneal spread, in particular, reduces quality of life and has a dismal outcome. In this issue of the JCI, Berlin and authors have made considerable advancements in understanding the cellular and molecular composition of multivisceral CRC metastasis in a sophisticated murine orthotopic organoid model and in humans. The study provides unprecedented insights into the complex biology of the disease and points toward the development of compartmentalized immune-therapeutic strategies...
March 1, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38418315/including-the-liver-in-the-visceral-allograft-impact-on-donor-specific-anti-hla-antibodies-and-long-term-outcomes
#19
JOURNAL ARTICLE
Dace Abele, Markus Gäbel, Mihai Oltean, Jonas Varkey, Johan Mölne, Nils Ekwall, Helena Borg, Hanna Jacobsson, Jan Holgersson, Gustaf Herlenius
Humoral immunity emerges as a risk factor for graft failure after visceral transplantation (VTx) and development of donor-specific anti-HLA antibodies (DSAs) has been linked with poor outcomes. In most cases, a simultaneous liver transplant can be safely performed in sensitized patients with DSA and appears protective against lymphocytotoxic antibodies. We investigated the incidence of acute (AR) and chronic rejection (CR) in 32 VTx without any B cell-depleting pre-treatment (6 isolated intestinal transplants (IT) and 26 liver-containing, multivisceral transplants (MVT) and assessed the presence of donor-specific antibodies (DSA) pre- and post-transplantation...
February 27, 2024: Human Immunology
https://read.qxmd.com/read/38410226/current-status-of-robot-assisted-total-pelvic-exenteration-focusing-on-the-field-of-urology-a-clinical-practice-review
#20
REVIEW
Jun Kamei, Tetsuya Fujimura
Total pelvic exenteration (TPE) is a highly invasive surgery associated with high rates of perioperative morbidity and mortality and is commonly performed for several types of locally advanced or recurrent pelvic cancers. It involves multivisceral resection, including the rectum, sigmoid colon, bladder, prostate, uterus, vagina, or ovaries, and urologists normally perform radical cystectomy or radical prostatectomy and urinary diversion in collaboration with colorectal surgeons and gynecologists. In the urological field, robot-assisted surgeries have been widely performed as one of the main minimally invasive procedures because of their superior perioperative or oncological outcomes compared to open or laparoscopic surgeries...
January 31, 2024: Translational Cancer Research
keyword
keyword
11125
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.